Please login to the form below

Not currently logged in
Email:
Password:

RotaTeq

This page shows the latest RotaTeq news and features for those working in and with pharma, biotech and healthcare.

Sanofi unit takes low-cost rotavirus vaccine into phase III

Sanofi unit takes low-cost rotavirus vaccine into phase III

and Merck &Co's RotaTeq which, while effective, are still unaffordable for many countries battling with the infection. ... III trials, promising to make it available at around one-tenth the price of Rotarix and RotaTeq.

Latest news

  • GSK's Rotarix vaccine resumes use in US

    They suggested doctors use Merck's RotaTeq vaccine instead. . On Friday (May 14, 2010), the agency reversed its decision, saying there is no evidence that porcine circovirus can infect or sicken

  • Virus found in GSK's Rotarix vaccine

    Preliminary testing on Merck's RotaTeq, another rotavirus vaccine, has found no traces of PCV1.

  • WHO recommends rotavirus vaccines

    Data on Merck's rotavirus vaccine, RotaTeq, from clinical trials in Bangladesh, Vietnam, Ghana, Mali, and Kenya are expected in the autumn.

  • GSK's Rotarix protects against commonest rotaviruses

    The company has already obtained EU marketing approval. However, Merck &Co's RotaTeq was approved in the US in February 2007, and an advisory committee of the US Centers for Disease ... Control and Prevention (CDC) recently voted to recommend that all

  • Pharma news in brief

    Last month, Merck's rival Rotateq vaccine gained US Food and Drug Administration (FDA) approval as well as a Centers for Disease Control recommendation that it would be reimbursable by the

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics